Scoping paper on the potential risk(s) of Garcinia cambogia oral consumption
Data from authoritative bodies
TOX/2025/41
In this guide
In this guideThis is a discussion paper. It does not reflect the views of the Committee. It should not be cited.
13. Multiple authoritative bodies have reviewed the data on G. cambogia. For example, in European and international vigilance systems several reports of hepatic, digestive (pancreatitis), cardiac and muscular (rhabdomyolysis) damage as a result of consumption of supplements containing G. cambogia have been identified.